17 Recruiting Pheochromocytoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Pheochromocytoma Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔ RECRUITING Phase1 💊 Investigational Drug / Biologic
Diagnosis of Pheochromocytoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Zanzalintinib in Unresectable and Progressive MPGGs
📍 Brigham and Women's Hospital (BWH) — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
📍 University of Texas Health Science Center — San Antonio, Texas
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
211At-MABG in Adults With Advanced Neuroendocrine Cancers
📍 University of Pennsylvania - Abramson Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔